Short interest in Hepion Pharmaceuticals Inc (NASDAQ:HEPA) decreased during the last reporting period, falling from 115.17K to 81.19K. This put 1.4% of the company's publicly available shares short.

Short interest for Hepion Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Hepion Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 54.64K shares traded per day, it would take 1.49 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.